Literature DB >> 30024809

Opioid Prescribing Rates by Congressional Districts, United States, 2016.

Lyndsey A Rolheiser1, Jack Cordes1, S V Subramanian1.   

Abstract

OBJECTIVES: To determine the extent to which opioid prescribing rates vary across US congressional districts.
METHODS: In an observational cross-sectional framework using secondary data, we constructed 2016 congressional district-level opioid prescribing rate estimates using a population-weighted methodology.
RESULTS: High prescribing rate districts were concentrated in the South, Appalachia, and the rural West. Low-rate districts were concentrated in urban centers.
CONCLUSIONS: In the midst of an opioid overdose crisis, we identified congressional districts of particular concern for opioid prescription saturation. Public Health Implications. The congressional district geography represents a policy-relevant boundary and a politically important level at which to monitor the crisis and determine program funding. Furthermore, in the context of the opioid crisis, knowing how congressional districts rank across the country and in states is useful in the creation of policies targeted to areas in need.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30024809     DOI: 10.2105/AJPH.2018.304532

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  8 in total

1.  Prescribing Associated with High-Risk Opioid Exposures Among Non-cancer Chronic Users of Opioid Analgesics: a Social Network Analysis.

Authors:  Keiki Hinami; Michael J Ray; Kruti Doshi; Maria Torres; Steven Aks; John J Shannon; William E Trick
Journal:  J Gen Intern Med       Date:  2019-08-16       Impact factor: 5.128

2.  Geospatial Analyses of Pain Intensity and Opioid Unit Doses Prescribed on the Day of Discharge Following Orthopedic Surgery.

Authors:  Patrick Tighe; François Modave; MaryBeth Horodyski; Matthew Marsik; G Lipori; Roger Fillingim; Hui Hu; Jennifer Hagen
Journal:  Pain Med       Date:  2020-08-01       Impact factor: 3.750

3.  Long-term use of hydrocodone vs. oxycodone in primary care.

Authors:  Rebecca Arden Harris; Henry R Kranzler; Kyong-Mi Chang; Chyke A Doubeni; Robert Gross
Journal:  Drug Alcohol Depend       Date:  2019-11-02       Impact factor: 4.852

Review 4.  Neuroleptanalgesia for acute abdominal pain: a systematic review.

Authors:  Andrew C Miller; Abbas M Khan; Alberto A Castro Bigalli; Kerry A Sewell; Alexandra R King; Shadi Ghadermarzi; Yuxuan Mao; Shahriar Zehtabchi
Journal:  J Pain Res       Date:  2019-02-26       Impact factor: 3.133

5.  Trends and associated factors of use of opioid, heroin, and cannabis among patients for emergency department visits in Nevada: 2009-2017.

Authors:  Pearl C Kim; Ji Won Yoo; Chris R Cochran; Seong-Min Park; Sungyoun Chun; Yong-Jae Lee; Jay J Shen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

6.  Ensemble learning to predict opioid-related overdose using statewide prescription drug monitoring program and hospital discharge data in the state of Tennessee.

Authors:  Michael Ripperger; Sarah C Lotspeich; Drew Wilimitis; Carrie E Fry; Allison Roberts; Matthew Lenert; Charlotte Cherry; Sanura Latham; Katelyn Robinson; Qingxia Chen; Melissa L McPheeters; Ben Tyndall; Colin G Walsh
Journal:  J Am Med Inform Assoc       Date:  2021-12-28       Impact factor: 7.942

7.  Evaluating Opioid Dispensing Rates among Pediatrics and Young Adults based on CURES Data Reporting in California from 2015-2019.

Authors:  Michael T Phan; Courtney Wong; Daniel M Tomaszewski; Zeev N Kain; Brooke Jenkins; Candice Donaldson; Michelle Fortier; Sun Yang
Journal:  J Contemp Pharm Prac       Date:  2021-03-03

8.  Receipt of multiple outpatient opioid prescriptions is associated with increased risk of adverse outcomes in youth: opioid prescribing trends, individual characteristics, and outcomes from 2005 to 2016.

Authors:  Melissa Pielech; Eric Kruger; William Evan Rivers; Harry E Snow; Kevin E Vowles
Journal:  Pain       Date:  2020-06       Impact factor: 7.926

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.